660 related articles for article (PubMed ID: 18779821)
21. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipocytokines in elderly postmenopausal women.
Ding QF; Hayashi T; Zhang XJ; Funami J; Ge L; Li J; Huang XL; Cao L; Zhang J; Akihisa I
J Diabetes Complications; 2007; 21(5):315-9. PubMed ID: 17825756
[TBL] [Abstract][Full Text] [Related]
22. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?
Hermans MP; Ahn SA; Amoussou-Guenou KD; Balde NM; Rousseau MF
Diabet Med; 2010 Apr; 27(4):417-22. PubMed ID: 20536513
[TBL] [Abstract][Full Text] [Related]
23. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
Calcaterra V; De Amici M; Klersy C; Torre C; Brizzi V; Scaglia F; Albanesi M; Albertini R; Allais B; Larizza D
Acta Biomed; 2009 Aug; 80(2):117-23. PubMed ID: 19848048
[TBL] [Abstract][Full Text] [Related]
24. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Cho GJ; Shin JH; Yi KW; Park HT; Kim T; Hur JY; Kim SH
Menopause; 2011 Oct; 18(10):1120-4. PubMed ID: 21694651
[TBL] [Abstract][Full Text] [Related]
25. Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status.
Van Campenhout A; Van Campenhout C; Lagrou AR; Abrams P; Moorkens G; Van Gaal L; Manuel-y-Keenoy B
Diabetes Metab Res Rev; 2006; 22(6):444-54. PubMed ID: 16506275
[TBL] [Abstract][Full Text] [Related]
26. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
28. Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
Osawa H; Ochi M; Tabara Y; Kato K; Yamauchi J; Takata Y; Nishida W; Onuma H; Shimizu I; Fujii Y; Miki T; Ohashi J; Makino H
Clin Endocrinol (Oxf); 2008 Jul; 69(1):74-80. PubMed ID: 18081734
[TBL] [Abstract][Full Text] [Related]
29. Metabolic syndrome and prediabetes identify overlapping but not identical populations.
Diamantopoulos EJ; Andreadis EA; Tsourous GI; Ifanti GK; Katsanou PM; Georgiopoulos DX; Vassilopoulos CV; Dimitriadis G; Raptis SA
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):377-83. PubMed ID: 16915541
[TBL] [Abstract][Full Text] [Related]
30. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
Jehn ML; Guallar E; Clark JM; Couper D; Duncan BB; Ballantyne CM; Hoogeveen RC; Harris ZL; Pankow JS
Am J Epidemiol; 2007 May; 165(9):1047-54. PubMed ID: 17284722
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Inoue H
Diabetes Metab Res Rev; 2009 Jan; 25(1):52-6. PubMed ID: 18677713
[TBL] [Abstract][Full Text] [Related]
32. High serum ferritin levels are associated with metabolic risk factors in non-obese Korean young adults: Korean National Health and Nutrition Examination Survey (KNHANES) IV.
Yoo KD; Ko SH; Park JE; Ahn YB; Yim HW; Lee WC; Park YM
Clin Endocrinol (Oxf); 2012 Aug; 77(2):233-40. PubMed ID: 21977991
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus infection, increased serum ferritin and hyperinsulinemia.
Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Palomo Gil S; Grilo Reina A
Rev Esp Enferm Dig; 2001 Oct; 93(10):639-48. PubMed ID: 11767488
[TBL] [Abstract][Full Text] [Related]
34. Serum ferritin levels and other indicators of organic iron as risk factors or markers in coronary artery disease.
Armaganijan D; Batlouni M
Rev Port Cardiol; 2003 Feb; 22(2):185-95; discussion 197-201. PubMed ID: 12768999
[TBL] [Abstract][Full Text] [Related]
35. Improved preoperative iron status assessment by soluble transferrin receptor in elderly patients undergoing knee and hip replacement.
Basora M; Deulofeu R; Salazar F; Quinto L; Gomar C
Clin Lab Haematol; 2006 Dec; 28(6):370-5. PubMed ID: 17105489
[TBL] [Abstract][Full Text] [Related]
36. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
37. Dietary and serum iron, body iron stores and coronary heart disease.
Gupta R; Rastogi S; Nagar R; Kastia S; Kaul V
J Assoc Physicians India; 2000 May; 48(5):489-92. PubMed ID: 11273140
[TBL] [Abstract][Full Text] [Related]
38. Association of elevated serum ferritin levels and the risk of gestational diabetes mellitus in pregnant women: The Camden study.
Chen X; Scholl TO; Stein TP
Diabetes Care; 2006 May; 29(5):1077-82. PubMed ID: 16644640
[TBL] [Abstract][Full Text] [Related]
39. Body iron is a contributor to oxidative damage of DNA.
Tuomainen TP; Loft S; Nyyssönen K; Punnonen K; Salonen JT; Poulsen HE
Free Radic Res; 2007 Mar; 41(3):324-8. PubMed ID: 17364961
[TBL] [Abstract][Full Text] [Related]
40. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome.
Henneman P; Janssens AC; Zillikens MC; Frolich M; Frants RR; Oostra BA; van Duijn CM; van Dijk KW
J Intern Med; 2010 Apr; 267(4):402-9. PubMed ID: 19912464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
